PTEN is an important tumor suppressor in endometrial cancer, and the identification of these molecular rearrangements can aid in better understanding of endometrial cancer biology and can also lead to the discovery of novel molecular targets for the detection, prognosis, and therapy. The gene discussed is PTEN; the disease is endometrial cancer.